Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SOTORASIB vs SPARSENTAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SOTORASIB vs SPARSENTAN: Safety Overview

Metric SOTORASIB SPARSENTAN
Total FAERS Reports 2,923 3,280
Deaths Reported 700 18
Death Rate 23.9% 0.5%
Hospitalizations 555 209
Average Patient Age 67.0 yrs 49.3 yrs
% Female Patients 47.8% 43.8%
FDA Approval Date Jan 20, 2023 Feb 17, 2023
Manufacturer Amgen Inc Travere Therapeutics, Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription